BCAX
Bicara Therapeutics Soars to New Heights: A Pivotal Year of Breakthroughs and Milestones
In a groundbreaking fourth quarter earnings call, Bicara Therapeutics unveiled an array of remarkable achievements that catapulted the clinical-stage biotech company to unprecedented heights. Under the leadership of CEO Claire Mazumdar, the company has been diligently pioneering bifunctional antibodies for targeted tumor modulation. Their innovative approach combines tumor targeting with